XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Stockholders' Deficiency (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Common Stock [Member]
Sep. 30, 2014
Additional Paid-In Capital [Member]
Sep. 30, 2014
Accumulated Deficit [Member]
Sep. 30, 2014
Accumulated Other Comprehensive (Loss) Income [Member]
Sep. 30, 2014
Treasury Stock [Member]
Dec. 31, 2013
Treasury Stock [Member]
Sep. 30, 2014
Noncontrolling Interest [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning Balance $ (21,609) $ 9,748 $ 0 $ (114,787) $ 22,860 $ (12,857) $ (12,857) $ 73,427
Beginning Balance (in shares)   97,482,998            
Net income (loss) 36,265     25,384       10,881
Change in net loss and prior service cost, net of income taxes 411       411      
Forward contract adjustments, net of income taxes 28       28      
Unrealized gain on long-term investment securities accounted for under the equity method, net of income taxes 2,299       2,299      
Change in net unrealized gain on investment securities available for sale, net of income taxes 13,074       13,074      
Net unrealized loss on investment securities available for sale reclassified into net income, net of income taxes 22       22      
Unrealized gain on investment securities, net of income taxes 13,096              
Total other comprehensive income 15,834              
Comprehensive income (loss) 52,099              
Distributions and dividends on common stock (121,340)   (84,524) (36,816)        
Restricted stock grant 100 100            
Restricted stock grant (in shares)   1,000,000            
Effect of stock dividend 0 520   (520)        
Effect of stock dividend (in shares)   5,195,856            
Note conversions, inclusive of taxes $1,006 63,149 510 62,639          
Note conversion, inclusive of taxes $1,006 (in shares)   5,107,050            
Beneficial conversion feature of notes payable, net of income taxes of $10,327 14,648   14,648          
Exercise of stock options 4,307 34 4,273          
Exercise of stock options (in shares)   339,683            
Tax benefit of options exercised 937   937          
Stock-based compensation 2,027   2,027          
Contributions made by non-controlling interest 2,676             2,676
Distributions to non-controlling interest (4,861)             (4,861)
Ending Balance $ (7,867) $ 10,912 $ 0 $ (126,739) $ 38,694 $ (12,857) $ (12,857) $ 82,123
Ending Balance (in shares)   109,125,587